The aim of this study was to evaluate the participation and yield of the faecal immunochemical test (FIT) in nonattendees for computed tomography colonography (CTC) or optical colonoscopy (OC) screening, in the setting of a randomized trial. In the SAVE trial, 16087 individuals were randomly assigned and invited to one of four interventions for colorectal cancer screening: (i) biennial FIT for three rounds; (ii) reduced-preparation CTC; (iii) fullpreparation CTC; and (iv) OC. Nonattendees of reducedpreparation CTC, full-preparation CTC and OC groups were invited to FIT. Here, we analysed the participation rate and the detection rate for cancer or advanced adenoma (advanced neoplasia) of FIT among nonattendees for reduced-preparation CTC, full-preparation CTC and OC. Nonattendees were 1721 of 2395 (71.9%) eligible invitees in the reduced-preparation CTC group, 1818 of 2430 (74.8%) in the full-preparation CTC group and 883 of 1036 (85.2%) in the OC group. Participation rates for FIT were 20.2% (347/1721) in nonattendees for reduced-preparation CTC, 21.4% (389/1818) in nonattendees for full-preparation CTC and 25.8% (228/883) in nonattendees for OC. Differences between both CTC groups and the OC group were statistically significant (P ≤ 0.01), whereas the difference between reduced-preparation and full-preparation CTC groups was not statistically significant (P = 0.38). The detection rate of FIT was not statistically significantly different among nonattendees for reduced-preparation CTC (0.9%; 3/347), nonattendees for full-preparation CTC (1.8%; 7/389) and nonattendees for OC (1.3%; 3/228) (P > 0.05). Offering FIT to nonattendees for CTC or OC increases the overall participation in colorectal cancer screening and enables the detection of additional advanced neoplasia.
Introduction
Screening programmes for colorectal cancer (CRC) are implemented in many European countries (Karsa et al., 2008; Zavoral et al., 2009; Schreuders et al., 2015) . They are based on the faecal occult blood test (FOBT) or endoscopic tests, namely flexible sigmoidoscopy (FS) and optical colonoscopy (OC). FOBT decreases CRC mortality (Hewitson et al., 2007) , FS is associated with reduction in CRC incidence and OC enables removal of precancerous lesions (Winawer et al., 1993; Atkin et al., 2010; Segnan et al., 2011) . FS and OC typically have a higher diagnostic yield, but a lower participation rate than FOBT (Hol et al., 2010; Lisi et al., 2010; Hassan et al., 2012; Stoop et al., 2012; Zorzi et al., 2012; Sali et al., 2015) . Recently, computed tomography colonography (CTC) has emerged as a potential screening test for CRC (Levin et al., 2008; Stoop et al., 2012; Sali et al., 2015) . Randomized trials have shown that participation in CTC screening is higher than that in OC screening (Stoop et al., 2012; Sali et al., 2015) , but lower than that in the faecal immunochemical test (FIT) (Sali et al., 2015) .
Offering FIT to nonattendees for FS screening has been proposed as a strategy to increase overall participation in CRC screening (Hol et al., 2012; Senore et al., 2013) .
The SAVE study is a randomized trial investigating four primary screening tests for CRC, namely reducedpreparation and full-preparation CTC, FIT and OC. The main outcomes of the trial at the first screening round were reported previously (Sali et al., 2015) . In the present report, we evaluated the participation and detection rate (DR) of FIT in subjects not attending CTC and OC as primary screening tests in the SAVE study.
Participants and methods

Study design and population
The SAVE study is an ongoing single-centre, randomized-controlled trial (Sali et al., 2013) . In a district of Florence, 16087 individuals aged 54-65 years, who had never been screened by the FIT regional programme, were allocated (8 : 2.5 : 2.5 : 1) with simple randomization to be invited to one of four interventions: (i) biennial FIT for three rounds, (ii) single CTC with reduced cathartic preparation, (iii) single CTC with full cathartic preparation and (iv) single OC.
Nonattendees of the reduced-preparation CTC, fullpreparation CTC and OC groups were subsequently invited to FIT according to the study protocol and constituted the basis of the present report.
The trial was approved by the Ethical Committee of the Local Health Unit of Florence (number: 432/2010). All participants provided their written informed consent.
Invitation procedures
Randomly assigned individuals were invited by mail to undergo one of the four screening tests: FIT, reducedpreparation CTC, full-preparation CTC and OC. Nonattendees of all groups received a reminder by mail. After 6 months, nonresponders to reminders belonging to reducedpreparation CTC, full-preparation CTC and OC groups were invited by mail to FIT. The subsequent offer of FIT in nonattendees of reduced-preparation CTC, full-preparation CTC and OC groups was not mentioned in the original invitation letter or in the reminder letter.
Screening procedure
Individuals were requested to collect the FIT test kit in any pharmacy of the town of Florence and to return faecal specimens to specific collection points.
The FIT was OC-SENSOR using the OC-SENSOR DIANA analyser (Eiken Chemical Co., Tokyo, Japan) with a cut-off of 20 μg haemoglobin/g faeces. Patients who tested positive were invited to colonoscopy work-up. All colorectal lesions were classified as follows: hyperplastic polyp, serrated, tubular, tubulovillous, or villous adenoma or adenocarcinoma (Schlemper et al., 2000) . Advanced adenoma was defined as any adenoma equal to or larger than 10 mm and/or with a villous histological component higher than 20% and/or with severe dysplasia. Advanced neoplasia was defined as cancer or advanced adenoma.
Statistical analysis
The analysis was based on the intention-to-treat principle. We measured the participation rate and DR for advanced neoplasia of FIT in nonattendees for reduced-preparation CTC, full-preparation CTC and OC. Moreover, the same outcomes were calculated for the two-step recruitment strategy (i.e. reduced-preparation CTC plus FIT, fullpreparation CTC plus FIT, OC plus FIT), taking into account the participation rate and advanced neoplasia detected in the reduced-preparation CTC, full-preparation CTC and OC groups of the SAVE trial, which were reported elsewhere (Sali et al., 2015) .
The participation rate for FIT was defined as the number of individuals undergoing FIT relative to the total number of nonattendees for the original assigned test. The participation rate for the two-step recruitment strategy was defined as the number of individuals undergoing the originally assigned test plus those undergoing FIT, relative to the total number of eligible invitees in each of the three groups. The DR was defined as the proportion of individuals with screen-detected advanced neoplasia over the total number of participants (to subsequent FIT invitation or to the two-step recruitment strategy) or eligible invitees.
As an additional analysis, participation rates for the twostep recruitment strategies were compared with the same figure of the original assigned FIT group of the SAVE trial, which was reported previously (Sali et al., 2015) .
Differences between groups were expressed as relative risk (RR) with 95% confidence intervals (CIs) and P-values were calculated using an exact binomial test. Two-sided P-values of less than 0.05 were considered significant. The analysis per socioeconomic status was based on a deprivation index constructed at a national level and divided into tertiles (Caranci and Costa, 2009 ).
We used the STATA software 12.0 (Stata Corp LP, College Station, Texas, USA) for the statistical analysis. The trial was registered with ClinicalTrials.gov (NCT01651624).
Results
Faecal immunochemical test participation in nonattendees
Nonattendees were 1721 of 2395 (71.9%) eligible invitees in the reduced-preparation CTC group, 1818 of 2430 (74.8%) in the full-preparation CTC group and 883 of 1036 (85.2%) in the OC group. From February to September 2014, nonattendees were invited to FIT. Participation rates for FIT were 20.2% (347/1721) among nonattendees for reduced-preparation CTC, 21.4% (389/1818) among nonattendees for full-preparation CTC and 25.8% (228/883) among nonattendees for OC. The participation rate was significantly lower both for the reduced-preparation CTC group with respect to the OC group (RR: 0.78, 95% CI: 0.66-0.93; P = 0.001) and for the full-preparation CTC group with respect to the OC group (RR: 0.83, 95% CI: 0.70-0.98; P = 0.01), whereas the difference between the reduced-preparation and the full-preparation CTC groups was not significant (RR: 0.94, 95% CI: 0.81-1.09; P = 0.38).
Sociodemographic characteristics of nonattendees for reduced-preparation CTC, full-preparation CTC and OC undergoing FIT are shown in Table 1 . In all groups, the participation rate for FIT was significantly higher among individuals older than 60 years of age and among women. Individuals with a low socioeconomic status had a lower participation rate with respect to those with average or high socioeconomic status in the reduced-preparation CTC group, but not in the full-preparation CTC and OC groups.
Faecal immunochemical test detection rate in nonattendees
FIT was positive in 15 of 347 (4.3%) individuals in the reduced-preparation CTC group, in 18 of 389 (4.6%) individuals in the full-preparation CTC group and in 11 of 228 (4.8%) individuals in the OC group. Compliance with colonoscopy work-up among individuals with positive FIT was 73.3% (11/15) in the reduced-preparation CTC group, 77.8% (14/18) in the full-preparation CTC group and 72.7% (8/11) in the OC group.
FIT detected three individuals with advanced neoplasia (one cancer and two advanced adenomas) in the reducedpreparation CTC group, seven (two cancers and five advanced adenomas) in the full-preparation CTC group and three (three advanced adenomas) in the OC group.
The DR for advanced neoplasia of FIT was 0.9% (3/347) in the reduced-preparation CTC group, 1.8% (7/389) in the full-preparation CTC group and 1.3% (3/228) in the OC group. Differences between groups were not significant: reduced-preparation CTC group versus OC group (RR: 0.66, 95% CI: 0.09-4.9; P = 0.62), full-preparation CTC group versus OC group (RR: 1.37, 95% CI: 0.31-8.19; P = 0.68) and reduced-preparation CTC group versus fullpreparation CTC group (RR: 0.48, 95% CI: 0.08-2.10; P = 0.30).
Two-step strategy participation and detection rate
Cumulative participation rates were 42.6% (1021/2395) for reduced-preparation CTC plus FIT, 41.2% (1001/2430) for full-preparation CTC plus FIT and 36.8% (381/1036) for OC plus FIT. The cumulative participation rate was higher for the combination of reduced-preparation CTC plus FIT with respect to OC plus FIT (RR: 1.16, 95% CI: 1.03-1.31; P = 0.01), whereas the differences between full-preparation CTC plus FIT and OC plus FIT (RR: 1.12, 95% CI: 0.99-1.26; P = 0.058) and between reducedpreparation CTC plus FIT versus full-preparation CTC plus FIT (RR: 1.03, 95% CI: 0.95-1.13; P = 0.44) were not significant. Table 2 shows a comparison of the participation rates between the two-step recruitment strategies and the original assignment FIT group (first of three rounds) of the SAVE trial.
The cumulative DRs per participant for advanced neoplasia were 3.9% (40/1021) for reduced-preparation CTC plus FIT, 3.7% (37/1001) for full-preparation CTC plus FIT and 3.7% (14/381) for OC plus FIT. None of the differences between groups was significant: reduced-preparation CTC plus FIT versus OC plus FIT (RR: 1.07, 95% CI: 0.57-2.12; P = 0.86), full-preparation CTC plus FIT versus OC plus FIT (RR: 1.01, 95% CI: 0.53-2.01; P = 1) and reducedpreparation CTC plus FIT versus full-preparation CTC plus FIT (RR: 1.06, 95% CI: 0.66-1.70; P = 0.80).
The cumulative DRs per invitee for advanced neoplasia were 1.7% (40/2395) for reduced-preparation CTC plus FIT, 1.5% (37/2430) for full-preparation CTC plus FIT and 1.4% (14/1036) for OC plus FIT. None of the differences between groups was significant: reduced-preparation CTC plus FIT versus OC plus FIT (RR: 1.23, 95% CI: 0.66-2.46; P = 0.51), full-preparation CTC plus FIT versus OC plus FIT (RR: 1.13, 95% CI: 0.59-2.26; P = 0.72) and reduced-preparation CTC plus FIT versus full-preparation CTC plus FIT (RR: 1.09, 95% CI: 0.68-1.76; P =0.69). Values are given as n or n (%). f-CTC, full-preparation computed tomography colonography; FIT, faecal immunochemical test; OC, optical colonoscopy; r-CTC, reduced-preparation computed tomography colonography.
a Because of missing values, the total number of individuals included in the analysis per socioeconomic status does not always add up to the total number of nonattendees or FIT participants. P-values were for the comparison of participation rates between subgroups and were calculated using Fischer's exact χ 2 -test.
Discussion
Our study is the first to report the effect of subsequent FIT invitation in nonattendees for screening CTC or OC. FIT increased the overall participation in CRC screening by 15-22% and enabled the detection of additional advanced neoplasia with respect to CTC and OC invitation alone.
The higher participation rate for FIT in nonattendees for OC (25.8%) than in nonattendees for reduced-preparation CTC (20.2%) or full-preparation CTC (21.4%) in our study could be related to the lower participation in screening OC (14.8%) observed in the SAVE trial with respect to reduced-preparation CTC (28.1%) and fullpreparation CTC (25.2%) (Sali et al., 2015) . Arguably, a considerable proportion of individuals who refused OC for its invasiveness were willing to undergo screening with a less burdensome test such as FIT. This effect was probably less pronounced for CTC because of its less invasive nature.
Two studies investigated the effect of FIT after FS. Participation rates for subsequent FIT were 19.3% in a population-based screening programme (Senore et al., 2013) and 25.0% in a randomized trial (Hol et al., 2012) . These figures are in line with our results.
In our study, the participation rate for FIT was higher among women and among individuals older than 60 years of age. This is a well-known feature of FIT (von Wagner et al., 2011; Hol et al., 2012; Zorzi et al., 2012; Senore et al., 2013; Blom et al., 2014) .
The SAVE trial showed that reduced-preparation CTC had higher participation among men than among women (Sali et al., 2015) . Our present data indicated that this characteristic can be balanced by the higher female participation for FIT among nonattendees for CTC, resulting in a synergic effect for the overall screening uptake.
The distribution per socioeconomic status of the FIT participants among nonattendees was similar to that observed in the SAVE trial (Sali et al., 2015) . One could have expected a higher participation from nonattendees with low socioeconomic status to the noninvasive test (FIT). Rather, our data seem to confirm the reluctant attitude towards screening of individuals of poor socioeconomic status (von Wagner et al., 2011).
The DRs for advanced neoplasia of FIT in nonattendees for reduced-preparation CTC, full-preparation CTC or OC screening were consistent with those obtained in Italian screening programmes (Zorzi et al., 2012) , in the SAVE trial (Sali et al., 2015) and in a study evaluating FIT after FS (Senore et al., 2013) .
Admittedly, a screening strategy offering FIT after CTC or OC had significantly lower participation (≥7%) than that for first-round FIT in the SAVE trial. The same figure was observed in the study by Hol et al. (2012) . Conceivably, the subsequent offer of two different tests, namely, CTC or OC and FIT, may generate uncertainty in the invited individuals. In fact, despite the improved overall participation in screening obtained by offering FIT to nonattendees for CTC or OC, a single offer of FIT remains the intervention for CRC screening with highest participation rates. This implies that the role of alternative interventions as CTC or OC requires justification by other factors such as higher diagnostic yield and longer intervals between screening tests within the frame of cost-effectiveness analyses.
Our study has two limitations. First, we are aware that the precision of DR estimates of FIT in nonattendees for reduced-preparation CTC, full-preparation CTC and OC is limited by the low number of advanced lesions detected. However, these DRs were comparable with those in the group of individuals participating in the SAVE study invited to FIT as a primary screening test (Sali et al., 2015) . Second, we offered a single round of FIT to nonattendees for reduced-preparation CTC, fullpreparation CTC and OC, whereas the effectiveness of a screening programme based on FIT relies on repeated rounds, which typically show variable participation and have a cumulative effect on DR.
In conclusion, our study showed that offering FIT to nonattendees for CTC or OC is a feasible option to considerably increase the overall participation in CRC screening by CT colonography or colonoscopy. A strategy offering reduced-preparation CTC plus FIT has higher participation than one offering colonoscopy plus FIT, with the same diagnostic yield. Participation in a two-step recruitment strategy constituted by CTC or OC plus FIT remains lower than single FIT recruitment in the context of a randomized trial.
